Post-approval upper airway stimulation predictors of treatment effectiveness in the ADHERE registry.

MedStar author(s):
Citation: European Respiratory Journal. 53(1), 2019 01.PMID: 30487205Institution: MedStar Washington Hospital CenterDepartment: OtolaryngologyForm of publication: Journal ArticleMedline article type(s): Journal ArticleSubject headings: *Electric Stimulation Therapy/is [Instrumentation] | *Implantable Neurostimulators | *Patient Satisfaction | *Product Surveillance, Postmarketing | *Sleep Apnea, Obstructive/th [Therapy] | Aged | Female | Germany | Humans | Logistic Models | Male | Middle Aged | Registries | Time Factors | Treatment Outcome | United StatesYear: 2019Local holdings: Available online from MWHC library: 1994 - presentISSN:
  • 0903-1936
Name of journal: The European respiratory journalAbstract: Copyright (c)ERS 2018.Upper airway stimulation (UAS) has been shown to reduce severity of obstructive sleep apnea (OSA). The aim of this registry was to identify predictors of UAS therapy response in an international multicenter registry. Patients who underwent UAS implantation in the US and Germany were enrolled in an observational registry. Data collected included patient characteristics, apnea-hypopnea index (AHI), Epworth Sleepiness Scale, objective adherence, adverse events, and patient satisfaction measures. Post hoc univariate and multiple logistic regression were performed to evaluate factors associated with treatment success. Between October 2016 and January 2018, 508 participants were enrolled from 14 centers. Median AHI was reduced from 34.0 to 7.0 events.h<sup>-1</sup>, median ESS reduced from 12 to 7 from baseline to final visit at 12-month post-implant. In post hoc analyses, for each 1-year increase in age, there was a 4% increase in odds of treatment success. For each 1 unit increase in BMI, there was 9% reduced odds of treatment success. In the multivariable model, age persisted in serving as statistically significant predictor of treatment success.In a large multicenter international registry, UAS is an effective treatment option with high patient satisfaction and low adverse events. Increasing age and reduced BMI are predictors of treatment response.All authors: Adhere Registry Investigators, Boon M, Chia S, Doghramji K, Harwick J, Heiser C, Hofauer B, Hsia J, Kezirian EJ, Kominsky A, Larsen C, Maurer JT, Mehra R, Schwab R, Soose R, Steffen A, Strohl K, Strollo PJ Jr, Thaler E, Ulrich Sommer J, Withrow KOriginally published: European Respiratory Journal. 2018 Nov 28Fiscal year: FY2019Digital Object Identifier: Date added to catalog: 2018-12-14
Holdings
Item type Current library Collection Call number Status Date due Barcode
Journal Article MedStar Authors Catalog Article 30487205 Available 30487205

Available online from MWHC library: 1994 - present

Copyright (c)ERS 2018.

Upper airway stimulation (UAS) has been shown to reduce severity of obstructive sleep apnea (OSA). The aim of this registry was to identify predictors of UAS therapy response in an international multicenter registry. Patients who underwent UAS implantation in the US and Germany were enrolled in an observational registry. Data collected included patient characteristics, apnea-hypopnea index (AHI), Epworth Sleepiness Scale, objective adherence, adverse events, and patient satisfaction measures. Post hoc univariate and multiple logistic regression were performed to evaluate factors associated with treatment success. Between October 2016 and January 2018, 508 participants were enrolled from 14 centers. Median AHI was reduced from 34.0 to 7.0 events.h<sup>-1</sup>, median ESS reduced from 12 to 7 from baseline to final visit at 12-month post-implant. In post hoc analyses, for each 1-year increase in age, there was a 4% increase in odds of treatment success. For each 1 unit increase in BMI, there was 9% reduced odds of treatment success. In the multivariable model, age persisted in serving as statistically significant predictor of treatment success.In a large multicenter international registry, UAS is an effective treatment option with high patient satisfaction and low adverse events. Increasing age and reduced BMI are predictors of treatment response.

English

Powered by Koha